|
WO2021075544A1
|
|
Ri-labeled humanized antibody
|
|
WO2021075546A1
|
|
Method for producing radioactive metal-labeled antibody
|
|
WO2021033530A1
|
|
Method for producing radioactive metal complex
|
|
WO2021002275A1
|
|
METHOD FOR PURIFYING 226Ra-CONTAINING SOLUTION, METHOD FOR PRODUCING 226Ra TARGET AND METHOD FOR PRODUCING 225Ac
|
|
WO2020256066A1
|
|
METHOD FOR PRODUCING 226Ra TARGET, METHOD FOR PRODUCING 225Ac, AND ELECTRODEPOSITION LIQUID FOR PRODUCTION OF 226Ra TARGET
|
|
CN111393306A
|
|
Apparatus for synthesizing radioiodinated compound
|
|
JP2020146456A
|
|
Radiopharmaceutical transfer device and method
|
|
JP2020166823A
|
|
Radiopharmaceutical ordering support device and ordering support method
|
|
WO2020066557A1
|
|
Target conveyance system, target body, and target transport method
|
|
WO2020045638A1
|
|
Radioactive imidazothiadiazole derivative compound
|
|
WO2020039962A1
|
|
Solution containing label precursor compound for radioactive fluorine-labeled compound
|
|
WO2019216223A1
|
|
Non-invasive diagnostic imaging agent for heart disease
|
|
CA3097101A1
|
|
Modified antibody and radioactive metal-labelled antibody
|
|
JP2020164441A
|
|
Method for producing radioactive iodine-labeled 15-(4-iodophenyl)-3(r, s)-methylpentadecanoic acid
|
|
JP2020166306A
|
|
Radiopharmaceutical ordering support device and ordering support method
|
|
JP2019125375A
|
|
Device and method for assisting nuclear medicine testing
|
|
JP2020054777A
|
|
Radioactive medicine administration device
|
|
JP2019128358A
|
|
Myocardial image display method, myocardial image display processing program, and myocardial image processor
|
|
WO2019159741A1
|
|
Medical image examination assistance apparatus and medical image examination assistance method
|
|
JP2020109380A
|
|
Diagnosis support method, diagnosis support program, and diagnosis support device
|
